26 Nov 2022Serum Institute of India
Covishield manufacturer SII duped of Rs. 1 crore, 7 arrested
In a major cheating and cyber fraud case, the Serum Institute of India (SII) has been duped of Rs. 1 crore.
03 Sep 2022Bombay High Court
Covishield death: Bombay HC notice to Centre, Serum Institute, DCGI
A man has filed a compensation suit against the Indian vaccine maker Serum Institute of India (SII) for Rs. 1,000 crore, claiming that the side effects of the Covishield vaccine killed his daughter last year.
27 Jan 2022Drugs Controller General of India
COVAXIN, Covishield will now be available in hospitals and clinics
The Drugs Controller General of India (DCGI) on Thursday granted approval for regular market sale to India's two most prevalent COVID-19 vaccines—COVAXIN and Covishield.
02 Dec 2021Union Health Ministry
COVID-19: India reports 9K+ infections; 477 more deaths
India on Thursday reported over 9,000 new COVID-19 cases with an active caseload of just under one lakh.
08 Oct 2021India
No quarantine for fully vaccinated Indians in UK from Monday
The United Kingdom has announced that Indians who are fully vaccinated with Covishield or any other UK-approved coronavirus vaccine will not have to quarantine upon arrival in Britain from Monday, October 11.
25 Sep 2021England
Date of birth on Co-WIN certificates for passengers traveling abroad
People who are fully inoculated and want to travel abroad will have a Co-WIN certificate with their full date of birth, official sources said on Saturday amid ongoing discussions between India and the UK over COVID-19 vaccination certificates.
22 Sep 2021S Jaishankar
UK recognizes Covishield, but Indians still need to quarantine
The United Kingdom on Wednesday revised its travel advisory, listing Covishield as an approved COVID-19 vaccine.
21 Sep 2021India
UK's decision to not recognize Covishield discriminatory, says India
India on Tuesday issued a sharp reaction to the United Kingdom's decision to not recognize Covishield as a legitimate COVID-19 vaccine.
21 Sep 2021S Jaishankar
India criticizes new UK travel rules; Jaishankar raises issue
India's External Affairs Minister S Jaishankar has pushed for a resolution of the COVID-19 quarantine issue faced by Indians in the United Kingdom.
20 Sep 2021Shashi Tharoor
Smacks of racism: Ramesh, Tharoor slam UK's COVID-19 travel rules
Former Union ministers Jairam Ramesh and Shashi Tharoor on Monday slammed the UK's COVID-19-related travel rules under which Indians vaccinated with Covishield would still be treated as unvaccinated.
24 Aug 2021Kochi
Kerala HC questions Centre about 84-day gap between Covishield doses
The Kerala High Court on Tuesday asked the Centre whether the 84-day gap between two doses of Covishield was based on the availability of the vaccine or its efficacy.
14 Aug 2021Serum Institute of India
SII's Poonawalla bats for booster dose, opposes mixing of vaccines
Serum Institute of India Chairman Cyrus Poonawalla on Friday said that taking a third or booster dose of Covishield, the coronavirus vaccine manufactured by his firm was desirable.
11 Aug 2021World Health Organization
India's drug regulator approves study on mixing Covishield, COVAXIN jabs
The Drugs Controller General of India (DCGI) has approved a proposal to conduct a study on the mixing of Covishield and COVAXIN COVID-19 vaccines.
08 Aug 2021COVID-19
Mixing of Covishield, COVAXIN vaccines gives positive results: ICMR study
A study conducted by the Indian Council of Medical Research (ICMR) has indicated that mixing and matching of COVID-19 vaccines Covishield and COVAXIN can yield better results.
04 Aug 2021India
Amid third wave fears, Covishield proven highly effective against Delta
The Delta variant is highly-transmissible and possibly leads to a more severe disease of COVID-19.
04 Aug 2021COVID-19
India mulls mixing Covishield, Sputnik doses; no recommendation yet
India is considering allowing the mixing of different COVID-19 vaccine doses in what could be the first mix-and-match inoculation.
28 Jul 2021Coronavirus
As vaccination pace remains slow, Centre may reduce private quota
The Centre may soon reduce the 25% quota of COVID-19 vaccine supply for private facilities for their failure to pick up the earmarked quota.
17 Jul 2021COVID-19
Government to procure 66 crore doses of Covishield, COVAXIN
The Centre has placed an order to procure 66 crore doses of Covishield and COVAXIN to be supplied between August and December this year, at a revised price of Rs. 205 and Rs. 215 per dose, respectively, excluding taxes, official sources said.
17 Jul 2021Europe
EU body says it didn't receive application for Covishield approval
The European Medicines Agency (EMA) said it has not received any application for the authorization of the coronavirus vaccine Covishield.
Seven EU nations, Switzerland approve India-made Covishield for 'Green Pass'
The European Union's (EU) Digital COVID Certificate framework to allow easier, restriction-free movement of vaccinated travelers within European countries—excluding India-made Covishield and COVAXIN vaccines—comes into force on Thursday.
'Not received Covishield approval request,' says EU body amid concerns
The Serum Institute of India (SII) has not yet applied for the approval of its coronavirus vaccine Covishield in the "Green Pass" issued by the European Union, according to a statement from the EU.
28 Jun 2021India
India takes up Covishield's exclusion from the EU's 'Green Pass'
Covishield, the Indian version of the Oxford-AstraZeneca vaccine, has been excluded from the European Union's "Green Pass."
10 Jun 2021COVID-19 Vaccine
AstraZeneca vaccine linked to small risk of low blood platelets
The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a small risk of developing a blood condition characterized by low platelet counts, according to a UK study.
10 Jun 2021Vaccine
After updating vaccine policy, Centre may renegotiate Covishield, COVAXIN prices
After India's COVID-19 vaccination policy was updated this week, the central government is likely to renegotiate prices for vaccines, a report suggested.
09 Jun 2021Punjab
Second Covishield dose in 28 days for some in Punjab
The second dose of the Covishield vaccine will now be administered after 28 days to people who have to travel abroad for specific purposes, Punjab Health Minister Balbir Singh Sidhu said on Tuesday.
27 May 2021Uttar Pradesh
1st dose Covishield, 2nd dose COVAXIN: Vaccination blunder in UP
In a grave oversight, a group of villagers in Uttar Pradesh received two shots of two different vaccines: COVAXIN and Covishield (both two-dose vaccines).
19 May 2021Karnataka
Karnataka targets vaccinating eligible population by 2021 end
The Karnataka government has set a goal to vaccinate all eligible people in the state by November end against coronavirus.
16 May 2021Vaccine
COVAXIN, Covishield effective, but produce fewer antibodies against B.1.617: Report
According to a series of early reports authored by scientists at the Indian Council of Medical Research (ICMR), COVAXIN and Covishield—vaccines deemed effective at generating an immune response against COVID-19—appear to generate only half as many antibodies against the B.1.617 variant.
13 May 2021Vaccine
Government panel recommends 12-16 week gap between Covishield doses
A government expert panel has reportedly recommended raising the time gap between two doses of the COVID-19 vaccine Covishield to 12-16 weeks.
04 May 2021Maharashtra
Give priority to Maharashtra in vaccine allocation: Tope to Poonawalla
Maharashtra Health Minister Rajesh Tope on Monday urged Serum Institute of India Chief Executive Officer Adar Poonawalla to give priority to the state in providing its anti-coronavirus vaccine, Covishield, as the government was ready to purchase doses from the Pune-based company.
28 Apr 2021Vaccine
Covishield price reduced to Rs. 300 for states: Adar Poonawalla
Adar Poonawalla, the CEO of the Serum Institute of India (SII), on Wednesday announced that the price of the COVID-19 vaccine Covishield was being reduced from Rs. 400 to Rs. 300 for states.
27 Apr 2021Maharashtra
Maharashtra may get Covishield supply only after May 20
Maharashtra Health Minister Rajesh Tope today said that the state may receive its supply of the Covishield vaccine only after May 20.
26 Apr 2021India
Coronavirus: United States will send raw material required for Covishield
Just as India is fighting a devastating second wave of coronavirus, the Joe Biden administration in the United States has pledged to help the Asian nation.
21 Apr 2021Vaccine
Coronavirus: 0.04% people infected after COVAXIN shot; 0.03% after Covishield
The central government on Wednesday said that a "very small" fraction of people have tested positive for COVID-19 after being vaccinated.
21 Apr 2021Coronavirus
SII fixes Covishield's price at Rs. 600 for private hospitals
Serum Institute of India (SII) will sell Covishield at Rs. 400 per shot to states and at Rs. 600 to private hospitals, the Pune-based vaccine manufacturer said today.
06 Apr 2021Vaccine
Covishield 90% effective if doses given 2-3 months apart: Poonawalla
The efficacy of the COVID-19 vaccine Covishield could increase to 90% if the two doses are given 2.5-3 months apart, Serum Institute of India CEO Adar Poonawalla said Monday.
05 Apr 2021Coronavirus Vaccine
118-year-old woman possibly oldest in India to get COVID-19 vaccine
A woman, whose age according to her Aadhaar Card is 118 years, has received her first dose of the COVID-19 vaccine in the Sagar district of Madhya Pradesh.
23 Mar 2021Coronavirus
COVAXIN, Covishield not linked to increased risk of blood clotting
There is no heightened risk of blood clotting after vaccinations with indigenous COVAXIN and Covishield, the coronavirus vaccine developed by AstraZeneca and the University of Oxford, a top government committee concluded, reports Indian Express.
22 Mar 2021India
Covishield dose gap to be increased to 6-8 weeks: Centre
The time gap between two doses of the Covishield vaccine should be increased to six-to-eight weeks for improved results, the central government has written to all states and Union Territories.
21 Mar 2021Vaccine
SII to delay shipments to Brazil, Morocco, and Saudi Arabia
The Serum Institute of India (SII) will reportedly be delaying COVID-19 vaccine supplies to Brazil, Saudi Arabia, and Morocco amid criticism that India is not vaccinating enough people at home.